Asunto(s)
Humanos , Adyuvantes Inmunológicos/clasificación , Adyuvantes Inmunológicos/farmacología , Sistema Inmunológico/efectos de los fármacos , Anticuerpos Monoclonales/farmacología , Glucocorticoides/farmacología , Inmunoglobulinas/farmacología , Interferones/farmacología , Interleucina-1/farmacología , Interleucina-2/farmacología , Células Asesinas Activadas por Linfocinas/efectos de los fármacos , Mediadores de Inflamación/farmacología , Metotrexato/farmacología , Trasplante de Médula Ósea/inmunologíaRESUMEN
In vitro effect of intravenous immunoglobulin (IVIG), Intraglobin F, on serum opsonic activity against Staphylococcus aureus was studied in 26 full term normal healthy neonates and 18 intrauterine growth retarded (IUGR) neonates by the polymorphonuclear leucocyte overlay method (requiring only a few drops of blood). Cord IgG and IgM levels were determined by single radial immunodiffusion. Serum opsonic activity against Staph. aureus was significantly lower in the IUGR neonates (49.1 +/- 0.89), as compared to that in normal neonates (61.96 +/- 0.73; P less than 0.001). Immunoglobulin supplementation in vitro at a concentration of 5 g/dl significantly enhanced the opsonic activity of IUGR neonate sera. Cord IgG levels of IUGR neonates were significantly lower (P less than 0.01) than IgG levels of normal neonates. No significant difference was observed in cord IgM levels between the normal and IUGR neonates.